| Symbol |
Name |
|
ANK2
|
ankyrin 2, neuronal
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2L13
|
BCL2-like 13 (apoptosis facilitator)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BNIP1
|
BCL2/adenovirus E1B 19kDa interacting protein 1
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DPF2
|
D4, zinc and double PHD fingers family 2
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
MOAP1
|
modulator of apoptosis 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD6
|
programmed cell death 6
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TRADD
|
TNFRSF1A-associated via death domain
|